These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 97702)

  • 1. Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
    Bürki HR; Asper H; Ruch W; Züger PE
    Psychopharmacology (Berl); 1978 May; 57(3):227-37. PubMed ID: 97702
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.
    Anlezark GM; Horton RW; Meldrum BS
    Biochem Pharmacol; 1978; 27(24):2821-8. PubMed ID: 581645
    [No Abstract]   [Full Text] [Related]  

  • 3. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of central monoaminergic neurons to lisuride: comparison with LSD.
    Rogawski MA; Aghajanian GK
    Life Sci; 1979 Apr; 24(14):1289-97. PubMed ID: 470543
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.
    Kehr W; Speckenbach W
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):163-9. PubMed ID: 305542
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of LSD25 and Deseril on the behaviour and level of biogenic amines in a rat's brain (author's transl)].
    Kleinrok Z; Jagiełło-Wójtowicz E; Borzecki Z
    Ann Univ Mariae Curie Sklodowska Med; 1976; 31():147-54. PubMed ID: 802166
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
    Vigouret JM; Bürki HR; Jaton AL; Züger PE; Loew DM
    Pharmacology; 1978; 16 Suppl 1():156-73. PubMed ID: 565520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.
    Burt DR; Creese I; Snyder SH
    Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of catecholamine mediation in the "aberrant" behaviour induced by lysergic acid diethylamide (LSD) in the rat.
    Dixon AK
    Experientia; 1968 Jul; 24(7):743-7. PubMed ID: 4387561
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
    White FJ; Appel JB
    Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simultaneous administration of LSD-25 and UML: cerebral levels of serotonin and conditioned behavior in the rat].
    Torre M; Torre E; Bogetto F
    Boll Soc Ital Biol Sper; 1974 Oct; 50(20):1643-6. PubMed ID: 4464008
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism.
    Markstein R; Herrling PL
    J Neurochem; 1978 Nov; 31(5):1163-72. PubMed ID: 702165
    [No Abstract]   [Full Text] [Related]  

  • 18. Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".
    Silbergeld EK; Hruska RE
    Psychopharmacology (Berl); 1979 Nov; 65(3):233-7. PubMed ID: 117494
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral reaction of rats pretreated with reserpine to LSD-25.
    Votava Z; Glisson SN; Himwich HE
    Int J Neuropharmacol; 1967 Nov; 6(6):543-7. PubMed ID: 5586670
    [No Abstract]   [Full Text] [Related]  

  • 20. D-lysergic acid diethylamide (LSD)--effect on biogenic amines excretion in man.
    Messiha FS; Grof S
    Biochem Pharmacol; 1973 Sep; 22(18):2352-4. PubMed ID: 4733686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.